Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial

MLA

Majid, Marjani, et al. “Evaluation of Silymarin for Management of Anti-Tuberculosis Drug Induced Liver Injury: A Randomized Clinical Trial.” Gastroenterology and Hepatology from Bed to Bench, vol. 12, no. 2, June 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8210e75d3e144a9b499e7414517bd75d&authtype=sso&custid=ns315887.

APA

Majid, M., Fanak, F., Makan, S., Mehdi, K. D., Afshin, M., Shadi, K., Payam, T., & Ali Akbar, V. (2019). Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial. Gastroenterology and Hepatology from Bed to Bench, 12(2).

Chicago

Majid, Marjani, Fahim Fanak, Sadr Makan, Kazempour Dizaji Mehdi, Moniri Afshin, Khabiri Shadi, Tabarsi Payam, and Velayati Ali Akbar. 2019. “Evaluation of Silymarin for Management of Anti-Tuberculosis Drug Induced Liver Injury: A Randomized Clinical Trial.” Gastroenterology and Hepatology from Bed to Bench 12 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8210e75d3e144a9b499e7414517bd75d&authtype=sso&custid=ns315887.